ABOUT

Contact

We welcome corrections, feedback, and inquiries. Here's how to reach us.

โŠ•

Content Corrections

If you believe any information on goglp1.com is inaccurate or outdated, let us know. We investigate all substantive correction requests within 48 hours and publish corrections with date stamps.

Email: [email protected]

Please include the page URL and a description of the inaccuracy. Supporting sources (FDA communications, peer-reviewed literature, provider documentation) help us resolve corrections faster.

โœŽ

Editorial Inquiries

Questions about our methodology, scoring, or editorial process.

Email: [email protected]

โŠž

Provider Submissions

If you represent a GLP-1 telehealth provider and would like to be considered for inclusion in our database, submit your provider for evaluation. We apply the same four-step protocol to every provider regardless of how we learn about them.

Email: [email protected]

Include: company name, states served, medications offered, pharmacy partner(s), licensing documentation, and a contact for our mystery-shopper team.

๐Ÿ”—

Partnership Inquiries

Affiliate partnerships, advertising, or other commercial relationships. All partnerships are subject to our editorial independence policy.

Email: [email protected]

โœ‰

General Inquiries

Everything else โ€” reader questions, press inquiries, accessibility feedback.

Email: [email protected]

Response Times

Content corrections 48-hour investigation, correction published within 72 hours
Editorial inquiries 3โ€“5 business days
Provider submissions Initial review within 5 business days
Partnership inquiries 5โ€“10 business days
General inquiries 5 business days

Important

goglp1.com is an editorial publication, not a healthcare provider. We cannot provide medical advice, prescribe medications, or intervene in provider-patient relationships. If you are experiencing a medical emergency, contact your healthcare provider or call 911 immediately.

If you have a complaint about a specific provider listed on our site, we recommend contacting the provider directly first. If the issue involves patient safety, we also encourage filing a report with the FDA MedWatch program.